Auna S.A. (NYSE:AUNA – Get Free Report) President Leon Jesus Zamora acquired 6,420 shares of the firm’s stock in a transaction that occurred on Friday, May 29th. The stock was bought at an average price of $4.15 per share, for a total transaction of $26,643.00. Following the completion of the transaction, the president owned 69,130 shares of the company’s stock, valued at $286,889.50. The trade was a 10.24% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link.
Leon Jesus Zamora also recently made the following trade(s):
- On Thursday, May 28th, Leon Jesus Zamora acquired 9,220 shares of Auna stock. The stock was bought at an average price of $4.17 per share, for a total transaction of $38,447.40.
- On Tuesday, May 26th, Leon Jesus Zamora acquired 30,000 shares of Auna stock. The stock was bought at an average price of $4.39 per share, for a total transaction of $131,700.00.
- On Wednesday, May 20th, Leon Jesus Zamora bought 5,814 shares of Auna stock. The stock was purchased at an average cost of $4.39 per share, with a total value of $25,523.46.
- On Wednesday, May 27th, Leon Jesus Zamora bought 23,273 shares of Auna stock. The stock was purchased at an average cost of $4.20 per share, with a total value of $97,746.60.
- On Tuesday, May 26th, Leon Jesus Zamora bought 8,727 shares of Auna stock. The stock was purchased at an average cost of $4.24 per share, with a total value of $37,002.48.
Auna Stock Up 0.2%
Shares of AUNA opened at $4.51 on Thursday. The firm has a market cap of $333.56 million, a P/E ratio of 17.34 and a beta of 0.81. The stock has a 50 day simple moving average of $5.15 and a two-hundred day simple moving average of $5.01. The company has a debt-to-equity ratio of 1.76, a current ratio of 1.09 and a quick ratio of 1.00. Auna S.A. has a 1 year low of $4.09 and a 1 year high of $6.85.
Wall Street Analysts Forecast Growth
AUNA has been the subject of several research reports. Zacks Research lowered Auna from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, March 31st. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Auna in a research note on Friday, March 27th. JPMorgan Chase & Co. dropped their price objective on Auna from $6.00 to $5.00 and set a “neutral” rating for the company in a research note on Tuesday, May 26th. Finally, Wall Street Zen lowered Auna from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 16th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $6.97.
Read Our Latest Stock Report on AUNA
Institutional Trading of Auna
A number of institutional investors have recently made changes to their positions in AUNA. World Investment Advisors purchased a new stake in shares of Auna during the fourth quarter valued at approximately $52,000. Clear Harbor Asset Management LLC purchased a new stake in shares of Auna during the fourth quarter valued at approximately $63,000. Sanctuary Advisors LLC purchased a new stake in shares of Auna during the first quarter valued at approximately $71,000. Virtu Financial LLC purchased a new stake in shares of Auna during the third quarter valued at approximately $75,000. Finally, Sage Investment Counsel LLC boosted its stake in shares of Auna by 60.0% during the fourth quarter. Sage Investment Counsel LLC now owns 16,000 shares of the company’s stock valued at $79,000 after purchasing an additional 6,000 shares during the period.
Auna Company Profile
Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.
The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.
See Also
- Five stocks we like better than Auna
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
- Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNow
- Palo Alto Networks Accelerates Growth 31% on AI Demand
Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.
